Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MDT | Medtronic PLC | -1.64% | 106.06 | 0.6% | $503.95m | |
| ABT | Abbott Laboratories | -2.87% | 81.95 | 0.8% | $383.00m | |
| TMO | Thermo Fisher Scientific Inc. | -3.24% | 269.15 | 1.0% | $365.75m | |
| ALGN | Align Technology, Inc. | -2.20% | 175.04 | 6.3% | $331.79m | |
| ISRG | Intuitive Surgical, Inc. | -3.14% | 484.58 | 2.4% | $277.10m | |
| BDX | Becton, Dickinson and Company | -2.64% | 248.44 | 1.1% | $274.53m | |
| EW | Edwards Lifesciences Corporation | -2.10% | 212.12 | 1.2% | $225.03m | |
| SYK | Stryker Corporation | -1.90% | 214.12 | 1.3% | $224.61m | |
| ZBH | Zimmer Biomet Holdings, Inc. | -2.43% | 133.78 | 1.7% | $198.44m | |
| BSX | Boston Scientific Corporation | -3.49% | 41.20 | 1.1% | $196.69m | |
| BAX | Baxter International Inc. | -2.42% | 85.10 | 1.7% | $184.94m | |
| DXCM | DexCom, Inc. | -0.47% | 173.55 | 8.3% | $172.32m | |
| ABMD | ABIOMED, Inc. | -2.99% | 189.59 | 3.3% | $153.79m | |
| WAT | Waters Corporation | -2.36% | 205.03 | 4.0% | $113.59m | |
| IDXX | IDEXX Laboratories, Inc. | -3.37% | 270.44 | 3.7% | $106.89m |
Company Profile
Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Bone Growth Therapies, Spinal Implants, Biologics, Orthofix Extremities, and Corporate. The Bone Growth Therapies segment manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants segment designs, develops, and markets a broad portfolio of motion preservation and implant products used in surgical procedures of the spine. The Biologics segment includes portfolio of regenerative products and tissue forms that allow physicians to successfully treat a variety of spinal, and orthopedic conditions. The Orthofix Extremities segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The Corporate segment comprises of the operating expenses and activities of the company. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.